Tools
Tools
Pironi, Loris, Steiger, Ezra, Joly, Francisca, Wanten, Geert, Chambrier, Cécile, Aimasso, Umberto, Sasdelli, Anna Simona, Szczepanek, Kinga, Jukes, Amelia, Di Caro, Simona, Theilla, Miriam, Kunecki, Marek, Daniels, Joanne, Serlie, Mireille, Poullenot, Florian, Cooper, Sheldon C., Rasmussen, Henrik Højgaard, Compher, Charlene, Crivelli, Adriana, Hughes, Sarah-Jane, Guglielmi, Francesco W., Rotovnik Kozjek, Nada, Schneider, Stéphane M., Ellegard, Lars, Thibault, Ronan, Matras, Przemysław, Zmarzly, Anna, Matysiak, Konrad, van Gossum, André, Forbes, Alastair 
ORCID: https://orcid.org/0000-0001-7416-9843, Wyer, Nicola, Taus, Marina, Virgili, Nuria M., O'Callaghan, Margie, Chapman, Brooke, Osland, Emma, Cuerda, Cristina, Sahin, Peter, Jones, Lynne, Dong Won Lee, Andre, Masconale, Luisa, Orlandoni, Paolo, Spaggiari, Corrado, Doitchinova-Simeonova, Maryana, Garde, Carmen, Serralde-Zúñiga, Aurora E., Olveira, Gabriel, Krznaric, Zeljko, Petrina Jáuregui, Estrella, Zugasti Murillo, Ana, Suárez-Llanos, José P. and Lal, Simon
(2020)
Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure.
Gut, 69 (10).
pp. 1787-1795.
ISSN 0017-5749
Preview |
PDF (Accepted_Manuscript)
- Accepted Version
Download (1MB) | Preview |
Abstract
Background and aim: No marker to categorise the severity of chronic intestinal failure (CIF) has been developed. A 1-year international survey was carried out to investigate whether the European Society for Clinical Nutrition and Metabolism clinical classification of CIF, based on the type and volume of the intravenous supplementation (IVS), could be an indicator of CIF severity. Methods: At baseline, participating home parenteral nutrition (HPN) centres enrolled all adults with ongoing CIF due to non-malignant disease; demographic data, body mass index, CIF mechanism, underlying disease, HPN duration and IVS category were recorded for each patient. The type of IVS was classified as fluid and electrolyte alone (FE) or parenteral nutrition admixture (PN). The mean daily IVS volume, calculated on a weekly basis, was categorised as <1, 1-2, 2-3 and >3 L/day. The severity of CIF was determined by patient outcome (still on HPN, weaned from HPN, deceased) and the occurrence of major HPN/CIF-related complications: Intestinal failure-associated liver disease (IFALD), catheter-related venous thrombosis and catheter-related bloodstream infection (CRBSI). Results: Fifty-one HPN centres included 2194 patients. The analysis showed that both IVS type and volume were independently associated with the odds of weaning from HPN (significantly higher for PN <1 L/day than for FE and all PN >1 L/day), patients' death (lower for FE, p=0.079), presence of IFALD cholestasis/liver failure and occurrence of CRBSI (significantly higher for PN 2-3 and PN >3 L/day). Conclusions: The type and volume of IVS required by patients with CIF could be indicators to categorise the severity of CIF in both clinical practice and research protocols.
| Item Type: | Article |
|---|---|
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 15 Jan 2020 05:06 |
| Last Modified: | 18 Apr 2023 08:30 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/73644 |
| DOI: | 10.1136/gutjnl-2018-318172 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |